Difference between revisions of "LncRNAWiki:P"
| (One intermediate revision by one other user not shown) | |||
| Line 26: | Line 26: | ||
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR" | |"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR" | ||
|promoter of CDKN1A antisense DNA damage activated RNA | |promoter of CDKN1A antisense DNA damage activated RNA | ||
| − | |cancer | + | |breast cancer |
|- | |- | ||
|''PAPPA-AS1'' | |''PAPPA-AS1'' | ||
| Line 304: | Line 304: | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
|- | |- | ||
| + | |- | ||
| + | |''P4HA3-AS1'' | ||
| + | |[[P4HA3-AS1]] | ||
| + | |N/A | ||
| + | |P4HA3 antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''PCSK6-AS1'' | ||
| + | |[[PCSK6-AS1]] | ||
| + | |N/A | ||
| + | |PCSK6 antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''PGR-AS1'' | ||
| + | |[[PGR-AS1]] | ||
| + | |AT1, AT2, AT3 | ||
| + | |PGR antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''POC1B-AS1'' | ||
| + | |[[POC1B-AS1]] | ||
| + | |RP11-734K2 | ||
| + | |4 | ||
| + | |POC1B antisense RNA 1 | ||
| + | |- | ||
| + | |''PPP1R12A-AS1'' | ||
| + | |[[PPP1R12A-AS1]] | ||
| + | |R12A-AS1 | ||
| + | |PPP1R12A antisense RNA 1 | ||
| + | |_ | ||
| + | |- | ||
| + | |''PRNT'' | ||
| + | |[[PRNT]] | ||
| + | |M8 | ||
| + | |prion locus lncRNA, testis expressed | ||
| + | |_ | ||
|} | |} | ||
Latest revision as of 12:40, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| PACERR | ENST00000608917.1 | "PACER, PTGS2-AS1" | PTGS2 antisense NFKB1 complex-mediated expression regulator RNA | inflammation and cancer |
| PANCR | PANCR | N/A | PITX2 adjacent non-coding RNA | _ |
| PANDAR | lnc-CDKN1A-1:1 | "P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR" | promoter of CDKN1A antisense DNA damage activated RNA | breast cancer |
| PAPPA-AS1 | PAPPA-AS1 | "PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156" | PAPPA antisense RNA 1 | _ |
| PAPPA-AS2 | PAPPA-AS2 | AGU1 | PAPPA antisense RNA 2 | stem cell differentiation |
| PART1 | ENST00000506884.1 | "DKFZP586D0823, NCRNA00206" | prostate androgen-regulated transcript 1 (non-protein coding) | prostate carcinogenesis |
| PARTICL | PARTICL | PARTICLE | promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | _ |
| PAUPAR | NONHSAT018635 | N/A | PAX6 upstream antisense RNA | _ |
| PAXIP1-AS1 | PAXIP1-AS1 | N/A | PAXIP1 antisense RNA 1 (head to head) | _ |
| PCA3 | ENST00000412654.1 | "DD3, NCRNA00019, PCAT3" | prostate cancer associated 3 (non-protein coding) | Prostate Cancer |
| PCAT1 | ENST00000561978.1 | "PCAT-1, PCA1" | prostate cancer associated transcript 1 (non-protein coding) | Prostate Cancer |
| PCAT14 | PCAT14 | N/A | prostate cancer associated transcript 14 (non-protein coding) | prostate cancer |
| PCAT18 | PCAT18 | LINC01092 | prostate cancer associated transcript 18 (non-protein coding) | metastatic prostate cancer |
| PCAT19 | PCAT19 | LINC01190 | prostate cancer associated transcript 19 (non-protein coding) | prostate cancer |
| PCAT29 | PCAT29 | N/A | prostate cancer associated transcript 29 (non-protein coding) | prostate cancer |
| PCAT4 | ENST00000504263.1 | "GDEP, PCAN1, PCA4" | prostate cancer associated transcript 4 (non-protein coding) | Prostate Cancer |
| PCAT5 | PCAT5 | TPCAT-10-36067 | prostate cancer associated transcript 5 (non-protein coding) | Prostate Cancer |
| PCAT6 | PCAT6 | "Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288" | N/A | prostate cancer |
| PCAT7 | ENST00000452148.2 | PCAN-R2 | prostate cancer associated transcript 7 (non-protein coding) | Prostate Cancer |
| PCBP2-OT1 | PCBP2-OT1 | TUC338 | PCBP2 overlapping transcript 1 | hepatocellular carcinoma |
| PCBP3-OT1 | PCBP3-OT1 | FLJ44028 | PCBP3 overlapping transcript 1 | DNA damage |
| PCF11-AS1 | PCF11-AS1 | ENST00000602322.1 | PCF11 anstisense RNA 1 | _ |
| PCGEM1 | NONHSAT076153 | ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA | Prostate-specific transcript 1 | prostate cancer |
| PCNA-AS1 | PCNA-AS1 | N/A | PCNA antisense RNA 1 | tumor |
| PEG13 | PEG13 | N/A | paternally expressed 13 | _ |
| PEG3-AS1 | PEG3-AS1 | "APEG3, NCRNA00155" | PEG3 antisense RNA 1 | _ |
| PICSAR | PICSAR | "PRED74, NLC1-C" | P38 inhibited cutaneous squamous cell carcinoma associated lincRNA | Cutaneous Squamous Cell Carcinoma |
| PINK1-AS | PINK1-AS | "FLJ00387, PINK1AS, naPINK1" | PINK1 antisense RNA | _ |
| PISRT1 | PISRT1 | NCRNA00195 | polled intersex syndrome regulated transcript 1 (non-protein coding RNA) | blepharophimosis syndrome |
| PR antisense transcripts | NONHSAT023851 | N/A | N/A | _ |
| PRINS | NONHSAT011777 | ENSG00000238115 | Psoriasis susceptibility-related RNA Gene Induced by Stress | psoriasis |
| PRKCQ-AS1 | PRKCQ-AS1 | ENST00000414894.1 | PRKCQ antisense RNA 1 | _ |
| PRNCR1 | NONHSAT129019 | N/A | prostate cancer associated non-coding RNA 1 | Prostate Cancer |
| PRR7-AS1 | PRR7-AS1 | N/A | PRR7 antisense RNA 1 | _ |
| PSMA3-AS1 | PSMA3-AS1 | FLJ31306 | PSMA3 antisense RNA 1 | _ |
| PSMD5-AS1 | PSMD5-AS1 | N/A | PSMD5 antisense RNA 1 (head to head) | _ |
| PTCSC1 | NONHSAT129210 | AK023948 | papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) | thyroid carcinoma |
| PTCSC2 | ENST00000430058.1 | N/A | papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) | papillary thyroid carcinoma |
| PTCSC3 | ENST00000556013.2 | N/A | papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) | psoriasis |
| PTENP1 | NONHSAT130775 | "PTENpg1, PTEN2, ENSG00000237984" | PTEN Pseudogene 1 | prostate cancer |
| PTENP1-AS | PTENP1-AS | PTENpg1-asRNA | PTENP1 antisense RNA | _ |
| PTPRJ-AS1 | PTPRJ-AS1 | N/A | PTPRJ antisense RNA 1 | _ |
| PVT1 | ENST00000513868.2 | "NCRNA00079, LINC00079, onco-lncRNA-100" | Pvt1 oncogene (non-protein coding) | breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer |
| PWAR1 | PWAR1 | "PAR1, PAR-1" | Prader Willi/Angelman region RNA 1 | _ |
| PWAR4 | PWAR4 | "PAR4, PAR-4" | Prader Willi/Angelman region RNA 4 | _ |
| PWAR5 | PWAR5 | "PAR5, PAR-5" | Prader Willi/Angelman region RNA 5 | _ |
| PWARSN | PWARSN | "PAR-SN, PARSN" | "Prader Willi/Angelman region RNA, SNRPN neighbor" | Prader-Willi syndrome |
| PWRN1 | NONHSAT040920 | NCRNA00198 | Prader-Willi region non-protein coding RNA 1 | Prader-Willi syndrome |
| PWRN2 | NONHSAT040875 | NCRNA00199 | Prader-Willi region non-protein coding RNA 2 | Prader-Willi syndrome |
| P4HA3-AS1 | P4HA3-AS1 | N/A | P4HA3 antisense RNA 1 | _ |
| PCSK6-AS1 | PCSK6-AS1 | N/A | PCSK6 antisense RNA 1 | _ |
| PGR-AS1 | PGR-AS1 | AT1, AT2, AT3 | PGR antisense RNA 1 | _ |
| POC1B-AS1 | POC1B-AS1 | RP11-734K2 | 4 | POC1B antisense RNA 1 |
| PPP1R12A-AS1 | PPP1R12A-AS1 | R12A-AS1 | PPP1R12A antisense RNA 1 | _ |
| PRNT | PRNT | M8 | prion locus lncRNA, testis expressed | _ |
